We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Inflammation Linked to Faulty Receptor

By Biotechdaily staff writers
Posted on 23 May 2002
In a study, researchers have found that lung injuries among mice lacking CD44 receptors developed inflammation that persisted until the receptors were restored. More...
The study was reported in the April 5, 2002, issue of Science.

The CD44 receptor, which is present on some types of white blood cells, binds sugar-containing molecules such as hyaluronan (HA) and helps regulate the response of injured tissue to inflammation. In the study, animals lacking CD44 receptors did not recover from lung injury, eventually dying, while normal mice recovered in about two weeks. Senior author Dr. Paul Noble, of the US Veterans Affairs Connecticut Health Care System (VA, West Haven, USA), said these findings will help researchers better understand why persistent inflammation occurs and how to develop a better understanding of the body's healing process.

"This is helping us understand some of the basic healing mechanisms and what circumstances promote inflammation where more common causes like infection just are not present,” said Dr. Noble.

Inhaling dust, smoke or other airborne pollutants can injure lung tissue. Should inflammation occur, lung tissue chemically signals blood cells carrying CD44 receptors that repair is needed. Without CD44 to mediate the clean-up of the cellular waste that occurs in injury and healing, irritation may intensify rather than subside. The investigators hope to show that faulty CD44 receptors are linked to cases of persistent inflammation and slow healing. "If we can understand these mechanisms then we can potentially interrupt them at various stages,” said Dr. Noble.



Related Links:
VA CT Health Care

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.